Good Syndrome Associated with Organizing Pneumonia.  Mancuso G, Salvadè I, Christe AL, Ogna A. Int J Allergy & Imm. (2024)

 

Type 1 diabetes and inborn errors of immunity: Complete strangers or 2 sides of the same coin? Mancuso G, Bechi Genzano C, Fierabracci A, Fousteri G. J Allergy Clin Immunol. (2023)

 

A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association. Roncareggi S, Girardi K, Fioredda F, Pedace L, Arcuri L, Badolato R, Bonanomi S, Borlenghi E, Cirillo E, Coliva T, Consonni F, Conti F, Farruggia P, Gambineri E, Guerra F, Locatelli F, Mancuso G, Marzollo A, Masetti R, Micalizzi C, Onofrillo D, Piccini M, Pignata C, Raddi MG, Santini V, Vendemini F, Biondi A, Saettini F.

J Clin Immunol. 2023

​

Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal" ; Heba M Bintalib, David M Lowe, Gaia Mancuso, Georgia Gkrepi , Suranjith L Seneviratne, Siobhan O Burns, John R Hurst (2022)

"Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multicenter study" ; Ramirez GA, Lanzillotta M, Ebbo M, Fernandez-Codina A, Mancuso G, Orozco-Galvez O, Dagna L, Schleinitz N, Martínez-Valle F, Culver EL, Della-Torre E. (2022)

"A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-centre cohort." ; Ramirez GA, Calvisi SL, DE Lorenzo R, DA Prat V, Borio G, Gallina G, Farolfi F, Cavallo L, Pascali M, Castellani J, Baccellieri D, Guzzo F, Baiardo Redaelli M, Azzolini ML, Alba AC, Zangrillo A, Bozzolo EP, Scotti R, DI Lucca G, Piemonti L, Rovere Querini P, D'Angelo A, Tresoldi M; COVID-BioB group. ; Minerva Med 2021 (2021)

"Utility of the '2019 ACR/EULAR classification criteria' for the management of patients with IgG4-related disease" ; Della-Torre E, Lanzillotta M, Germanò T, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L. ; Semin Arthritis Rheum. (2021)

"Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature." ; Moroni L, Righini P, Ramirez GA, Farina N, Mancuso G, Bozzolo E, Rodríguez-Pintó I, Cervera R, Nano G, Dagna L. ; Lupus (2021)

"Utility of the '2019 ACR/EULAR classification criteria' for the management of patients with IgG4-related disease" ; Della-Torre E, Lanzillotta M, Germanò T, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L ; Semin Arthritis Rheum. (2021)

"Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19" ; Ramirez GA, Bozzolo EP, Gobbi A, Castelli E, Centurioni C, DI Meo M, Della Torre E, DI Scala F, Morgillo A, Marinosci A, Miglio M, Scarpellini P, Tassan Din C, Castiglioni B, Oltolini C, Ripa M, DI Terlizzi G, DA Prat V, Damanti S, Scotti R, DI Lucca G, Baiardo Redaelli M, Plumari VP, Moizo E, Carcó F, Silvani P, DE Cobelli F, Landoni G, Tresoldi M; COVID-BioB group. ; Panminerva Med (2021)

"Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease." ; Mancuso G, Jofra T, Lanzillotta M, Aiuti A, Cicalese MP, di Colo G, Dagna L, Fousteri G, Della-Torre E. ; Rheumatology (Oxford). (2021)

"Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study" ; Della-Torre E, Lanzillotta M, Campochiaro C, Di-Colo G, Mancuso G, Capurso G, Falconi M, Dagna L ; Eur J Intern Med. (2021)

"Urgent manifestations of immunoglobulin G4-related disease" ; Della-Torre E, Mancuso G, Lanzillotta M, Ramirez GA, Arcidiacono PG, Capurso G, Falconi M, Dagna ; Scand J Rheumatol (2021)
Persistence of Tfh cells after rituximab is associated with IgG4-related disease relapse" ; Mancuso G, Lanzillotta M, Della Torre E (2021)

"IgG4-related disease of the oral cavity. Case series from a large single-center cohort of Italian patients" ; Rampi A, Lanzillotta M, Mancuso G, Vinciguerra A, Dagna L ; Int J Environ Res Public Health (2020)

"Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation:an open-label cohort study" ; Della-Torre E, Campochiaro C, Cavalli G, De Luca G, Napolitano A, La Marca S, Boffini N, Da Prat V, Di Terlizzi G, Lanzillotta M, Rovere Querini P, Ruggeri A, Landoni G, Tresoldi M,Ciceri F, Zangrillo A, De Cobelli F, Dagna L; SARI-RAF Study Group; SARI-RAF Study Group members ; Ann Rheum Dis (2020)

"Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes" ; Lanzillotta M, Campochiaro C, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L, Della-Torre E ; Rheumatology (Oxford) (2020)

"Advances in the diagnosis and management of IgG4 related disease" ; Lanzillotta M, Mancuso G, Della-Torre E ; BMJ (2020)

"Colchicine as a new therapeutic option for antithyroid arthritis syndrome" ; Mancuso G, Boffini N, Dagna L, Della-Torre E ; Oxford Rheumatology (2020)

"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohortstudy" ; Campochiaro C, Della-Torre E, Cavalli G, De Luca G, Ripa M, Boffini N, Tomelleri A, Baldissera E,Rovere-Querini P, Ruggeri A, Monti G, De Cobelli F, Zangrillo A, Tresoldi M, Castagna A, Dagna L; TOCIRAFStudy Group. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. ; Eur J Intern Med (2020)

​

Measurement of intra-abdominal pressure in large incisional hernia repair to prevent abdominal compartmental syndrome. Angelici AM, Perotti B, Dezzi C, Amatucci C, Mancuso G, Caronna R, Palumbo P. G Chir. (2016)